Early Apical Release vs Classic Holmium Laser Enucleation of the Prostate: Randomized Controlled Trial Comparing Post-Operative Incontinence Rates and Surgical Outcomes

Completed · Not applicable

Conditions studied: Benign Prostatic Hyperplasia

In brief

To determine if early apical release holmium enucleation of the prostate (EAR HoLEP), as a surgical treatment for benign prostatic hyperplasia, reduces post-operative urinary incontinence compared to classic HoLEP.

Key facts

Study ID

NCT04566588

Run by

University of Kansas Medical Center

People needed

12

Starts

2020-06-25

Expected to finish

2021-05-11

Last updated by the study team

2024-10-02

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Patients must be 18 years of age or older
• Patients must present to clinic with a diagnosis of benign prostatic hyperplasia
• Patients must be scheduled to undergo a holmium laser enucleation of the prostate

You may not qualify if…

• Patients with previous surgical management of BPH
• Patients with prostate biopsy revealing high risk prostate cancer
• Patients with a concomitant neurogenic bladder diagnosis (SCI, Parkinson, MS, cerebral palsy)

Where it is running

• University of Kansas Health System — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.